News

Scope Biosciences secures follow-on investment to scale up its CRISPR diagnostics platform

Niek Savelkoul 6/16/25 Niek Savelkoul 6/16/25

Scope Biosciences secures follow-on investment to scale up its CRISPR diagnostics platform

Read More

Scope Biosciences secures €2.5 Million EIC-Transition grant to revolutionize Point-of-Care diagnostics with the CRISPR-Cas based scopeDx platform

Niek Savelkoul 3/7/24 Niek Savelkoul 3/7/24

Scope Biosciences secures €2.5 Million EIC-Transition grant to revolutionize Point-of-Care diagnostics with the CRISPR-Cas based scopeDx platform

Read More

Scope Biosciences raises 500K investment from SHIFT and Oost NL

Niek Savelkoul 10/23/23 Niek Savelkoul 10/23/23

Scope Biosciences raises 500K investment from SHIFT and Oost NL

Read More

Laboratory at Campus Wageningen

Niek Savelkoul 4/5/22 Niek Savelkoul 4/5/22

Laboratory at Campus Wageningen

Read More

Scope Biosciences raises €1M funding in a partnership with GenDx; experts in transplant diagnostics

Niek Savelkoul 11/5/21 Niek Savelkoul 11/5/21

Scope Biosciences raises €1M funding in a partnership with GenDx; experts in transplant diagnostics

Read More